IDEAYA Biosciences, Inc.
IDYA
$28.32
$0.110.39%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -39.68% | -94.77% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -39.68% | -94.77% | |||
| Cost of Revenue | 10.54% | 4.34% | |||
| Gross Profit | -17.75% | -160.66% | |||
| SG&A Expenses | 2.82% | 15.00% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 9.16% | 6.10% | |||
| Operating Income | -14.78% | -187.20% | |||
| Income Before Tax | -18.33% | -169.83% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -18.33% | -169.83% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -18.33% | -169.83% | |||
| EBIT | -14.78% | -187.20% | |||
| EBITDA | -14.93% | -186.01% | |||
| EPS Basic | -18.17% | -169.79% | |||
| Normalized Basic EPS | -5.53% | -178.14% | |||
| EPS Diluted | -17.68% | -170.98% | |||
| Normalized Diluted EPS | -5.53% | -179.18% | |||
| Average Basic Shares Outstanding | 0.13% | 0.06% | |||
| Average Diluted Shares Outstanding | 0.13% | -1.24% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||